Walgreens Boots Alliance Earnings Mixed, Forecast In-Line

NASDAQ: WBA | Walgreens Boots Alliance, Inc. News, Ratings, and Charts

WBA – Beats Wall Street consensus EPS estimates by $0.01. Misses on revenues.

Drug store giant Walgreens Boots Alliance Inc (NASDAQ:WBA) early Thursday posted mixed Q1 earnings results and offered an in-line outlook as it works with the FTC to close its acquisition of Rite Aid.

The Deerfield, IL-based company reported Q1 EPS of $1.10, which was $0.01 better than the $1.09 that analysts had expected. Revenues fell 1.8% from last year to $28.5 billion, missing Wall Street’s view of $29.27 billion.

Walgreens noted that retail pharmacy comps in the U.S. rose 1.1% from last year, while pharmacy sales jumped 2.5%. Pharmacy sales accounted for 69.1% of the overall U.S. revenue in the latest period. Comparable pharmacy sales increased 2.0%.

On a constant currency basis, comparable international store sales fell 0.1%, while comparable pharmacy sales fell 0.5%.

Looking ahead, Walgreens Boots Alliance, Inc. (WBA - Get Rating) forecast full-year 2017 EPS to range from $4.90 to $5.20, up from a prior range of $4.85 to $5.20. On average, Wall Street analysts are looking for EPS of $5.00 for the year.

The company commented via press release:

“Overall we are pleased with the progress this quarter, with results in line with our expectations. We continue to anticipate that growth in the second half of fiscal 2017 will reflect the new strategic pharmacy partnerships we announced last year. As a result, we have raised the lower end of our fiscal year guidance by 5 cents per share. In addition, we continue to work toward closing the pending acquisition of Rite Aid Corporation in the early part of this calendar year.”

Walgreens Boots Alliance Inc shares rose $0.66 (+0.8%) in premarket trading Thursday. Year-to-date, Walgreens Boots Alliance, Inc. (WBA - Get Rating) has gained 0.27%, versus a 1.36% rise in the benchmark S&P 500 index during the same period.

Walgreens Boots Alliance, Inc. (WBA - Get Rating) currently has an StockNews.com POWR Rating of A (Strong Buy), and is ranked #1 of 5 stocks in the Medical – Drug Stores category.

9 "Must Own" Growth Stocks For 2019

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Top Stories on StockNews.com

: ACB | Aurora Cannabis Inc. Common Shares News, Ratings, and Charts

Are shares of Aurora Cannabis (ACB) getting ready to break out?

Aurora Cannabis has been under downward pressure lately, primarily because of the broader market becoming increasingly risk averse.
NYSE: ORCL | Oracle Corporation Common Stock News, Ratings, and Charts

Macquarie Research downgrades Oracle (ORCL) to Neutral

Oracle Corporation was downgraded Tuesday by Macquarie.
NASDAQ: GOOGL | Alphabet Inc. - Class A Common Stock News, Ratings, and Charts

Google (GOOGL) Calendar experiencing a worldwide outage

Google’s website says it has been experiencing a service disruption since about 10:22 a.m. Eastern.
NYSE: BA | Boeing Company (The) Common Stock News, Ratings, and Charts

Boeing (BA) receives a new order for 737 Max planes from British Airways' parent company

IAG said it would buy 200 737 Max planes, orders for which ground to a halt after two fatal crashes.
: hexo | HEXO Corp. Common Shares News, Ratings, and Charts

After its recent dip, is pot stock Hexo (HEXO) a Buy?

Note that the HEXO stock price is about 50% off its 52-week high.

Read More Stories

More Walgreens Boots Alliance, Inc. (WBA) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All WBA News
Page generated in 2.5264 seconds.